Form 4 for CRH CRH plc
Accepted 2025-03-05 00:00:00 ET · period of report 2025-03-03 · accession 0000950170-25-033705 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-03-05 | 2025-03-03 | CRH | Creech Nathan | Pres, Americas Division | M - OptEx | $0.00 | +7,406 | 123.7K | +6% | $0 |
| D | 2025-03-05 | 2025-03-03 | CRH | Creech Nathan | Pres, Americas Division | A - Grant | $0.00 | +53.2K | 116.3K | +84% | $0 |
| D | 2025-03-05 | 2025-03-03 | CRH | Creech Nathan | Pres, Americas Division | F - Tax | $99.97 | -23.8K | 99.9K | -19% | -$2.38M |
| D | 2025-03-05 | 2025-03-03 | CRH | Creech Nathan | Pres, Americas Division | M - OptEx | — | -6,786 | 16.5K | -29% | — |
| D | 2025-03-05 | 2025-03-03 | CRH | Creech Nathan | Pres, Americas Division | A - Grant | — | +5,247 | 21.8K | +32% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2025-03-03 | M | A | 7,406 | $0.00 | 123,729 | D | — | — | (F2) Reflects the vesting and release of a 2022 time-based conditional award as defined in the 2014 Deferred Share Bonus Plan (the "DSB Plan Rules"), of which, pursuant to the determination of the Compensation Committee, a total of 7,406 shares vested on March 3, 2025, including the award of 620 additional Ordinary Shares as dividend equivalents. Subject to the determination of the Compensation Committee, the remaining awards of 9,188 shares and 7,341 shares are expected to vest in March 2026 and March 2027, respectively. In accordance with the DSB Plan Rules, dividend equivalents will apply to these awards and, to the extent awarded, will be reported at the time of vesting. |
| 2 | Common | Ordinary Shares | 2025-03-03 | A | A | 53,157 | $0.00 | 116,323 | D | — | — | (F1) Reflects the vesting and release of awards granted in 2022 under the 2014 Performance Share Plan Rules on March 3, 2025 (including the award of 4,453 additional Ordinary Shares as dividend equivalents), pursuant to certification of the achievement of pre-established performance goals by the Compensation Committee of the Board of Directors of the Issuer (the "Compensation Committee"). |
| 3 | Common | Ordinary Shares | 2025-03-03 | F | D | 23,833 | $99.97 | 99,896 | D | — | — | (F3) Mandatory withholding of sufficient Ordinary Shares to cover applicable tax liabilities arising in connection with the aforementioned awards. |
| 4 | Derivative | Deferred Share Award | 2025-03-03 | M | D | 6,786 | — | 16,529 | D | $0.00 · — to — | 6,786 Ordinary Shares | (F2) Reflects the vesting and release of a 2022 time-based conditional award as defined in the 2014 Deferred Share Bonus Plan (the "DSB Plan Rules"), of which, pursuant to the determination of the Compensation Committee, a total of 7,406 shares vested on March 3, 2025, including the award of 620 additional Ordinary Shares as dividend equivalents. Subject to the determination of the Compensation Committee, the remaining awards of 9,188 shares and 7,341 shares are expected to vest in March 2026 and March 2027, respectively. In accordance with the DSB Plan Rules, dividend equivalents will apply to these awards and, to the extent awarded, will be reported at the time of vesting. |
| 5 | Derivative | Deferred Share Award | 2025-03-03 | A | A | 5,247 | — | 21,776 | D | $0.00 · — to — | 5,247 Ordinary Shares | (F4) Reflects time-based conditional awards, as defined in the DSB Plan Rules, of which, subject to the determination of the Compensation Committee, the balance will vest in March 2028. In accordance with the DSB Plan Rules, dividend equivalents will apply to the Award and, to the extent awarded, will be reported at the time of vesting. |